Physicians’ views on patient participation in choice of oral anticoagulants in atrial fibrillation-a qualitative study

Patients’ preferences for new versus old anticoagulants: a mixed-method vignette-based study

(2017) Beata Bajorek et al.   European Journal of Cardiovascular Nursing

Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments

(2017) Anne Katrine Eek et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Important factors affecting the choice of an oral anticoagulant may be missed in database studies

(2017) E. Aarnio et al.   JOURNAL OF INTERNAL MEDICINE

Initiation of anticoagulation in atrial fibrillation: which factors are associated with choice of anticoagulant?

(2017) A. Gundlund et al.   JOURNAL OF INTERNAL MEDICINE

Patient values and preferences for antithrombotic therapy in atrial fibrillation

(2017) Angela Ji et al.   THROMBOSIS AND HAEMOSTASIS

Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs

(2017) Jennifer Lofland et al.   Patient Preference and Adherence

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort

(2017) Clara L. Rodríguez-Bernal et al.   Frontiers in Pharmacology

Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

(2016) Zardasht Oqab et al.   CANADIAN JOURNAL OF CARDIOLOGY

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPACE

The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation

(2016) Nathaniel Moulson et al.   POSTGRADUATE MEDICAL JOURNAL

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation

(2016) Michelle Sholzberg et al.   PLoS One

Factors Driving Anticoagulant Selection in Patients With Atrial Fibrillation in the United States

(2015) Julie C. Lauffenburger et al.   AMERICAN JOURNAL OF CARDIOLOGY

Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study

(2015) Pasquale Pignatelli et al.   European Journal of Internal Medicine

Preferences for anticoagulation therapy in atrial fibrillation: the patients’ view

(2015) Björn Böttger et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation— Quality and Cost Implications

(2014) Nihar R. Desai et al.   AMERICAN JOURNAL OF MEDICINE

Shared Decision Making in Atrial Fibrillation

(2014) Luke Seaburg et al.   CIRCULATION

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013

(2014) J. B. Olesen et al.   EUROPACE

The criteria of the Italian Federation of Thrombosis Centres on DOACs: a “real world” application in nonvalvular atrial fibrillation patients already on Vitamin K Antagonist

(2014) Doris Barcellona et al.   Internal and Emergency Medicine

Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data

(2014) Taru Hallinen et al.   BMJ Open

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

(2013) B. P. Krijthe et al.   EUROPEAN HEART JOURNAL

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study

(2013) Mojtaba Vaismoradi et al.   Nursing & Health Sciences

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE